Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1841 1
1866 1
1867 1
1869 5
1870 6
1871 2
1872 4
1873 2
1875 1
1876 3
1879 1
1880 3
1881 4
1882 1
1883 3
1884 1
1885 1
1888 1
1889 2
1890 2
1893 1
1901 2
1902 1
1903 1
1925 1
1927 1
1928 2
1943 1
1945 2
1946 6
1947 2
1948 6
1949 4
1950 5
1951 7
1952 10
1953 8
1954 15
1955 17
1956 9
1957 19
1958 14
1959 15
1960 25
1961 21
1962 23
1963 28
1964 32
1965 21
1966 13
1967 15
1968 12
1969 10
1970 15
1971 24
1972 33
1973 36
1974 31
1975 33
1976 28
1977 42
1978 36
1979 57
1980 47
1981 43
1982 55
1983 44
1984 56
1985 72
1986 77
1987 73
1988 53
1989 68
1990 78
1991 94
1992 108
1993 133
1994 133
1995 86
1996 97
1997 93
1998 89
1999 101
2000 97
2001 119
2002 121
2003 114
2004 133
2005 138
2006 196
2007 189
2008 199
2009 198
2010 240
2011 260
2012 263
2013 299
2014 289
2015 264
2016 299
2017 289
2018 315
2019 303
2020 316
2021 393
2022 384
2023 391
2024 388
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,882 results

Results by year

Filters applied: . Clear all
Page 1
Whole-genome landscape of pancreatic neuroendocrine tumours.
Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davì MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative; Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM. Scarpa A, et al. Among authors: anderson mj. Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15. Nature. 2017. PMID: 28199314 Free article.
Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y, Katsnelson L, Gritsenko MA, Hu Y, Reva B, Hong R, Wang YT, Kolodziejczak I, Lu RJ, Tsai CF, Bu W, Liu W, Guo X, An E, Arend RC, Bavarva J, Chen L, Chu RK, Czekański A, Davoli T, Demicco EG, DeLair D, Devereaux K, Dhanasekaran SM, Dottino P, Dover B, Fillmore TL, Foxall M, Hermann CE, Hiltke T, Hostetter G, Jędryka M, Jewell SD, Johnson I, Kahn AG, Ku AT, Kumar-Sinha C, Kurzawa P, Lazar AJ, Lazcano R, Lei JT, Li Y, Liao Y, Lih TM, Lin TT, Martignetti JA, Masand RP, Matkowski R, McKerrow W, Mesri M, Monroe ME, Moon J, Moore RJ, Nestor MD, Newton C, Omelchenko T, Omenn GS, Payne SH, Petyuk VA, Robles AI, Rodriguez H, Ruggles KV, Rykunov D, Savage SR, Schepmoes AA, Shi T, Shi Z, Tan J, Taylor M, Thiagarajan M, Wang JM, Weitz KK, Wen B, Williams CM, Wu Y, Wyczalkowski MA, Yi X, Zhang X, Zhao R, Mutch D, Chinnaiyan AM, Smith RD, Nesvizhskii AI, Wang P, Wiznerowicz M, Ding L, Mani DR, Zhang H, Anderson ML, Rodland KD, Zhang B, Liu T, Fenyö D; Clinical Proteomic Tumor Analysis Consortium. Dou Y, et al. Among authors: anderson ml. Cancer Cell. 2023 Sep 11;41(9):1586-1605.e15. doi: 10.1016/j.ccell.2023.07.007. Epub 2023 Aug 10. Cancer Cell. 2023. PMID: 37567170 Free PMC article.
Treatment approaches for patients with TP53-mutated mantle cell lymphoma.
Lew TE, Minson A, Dickinson M, Handunnetti SM, Blombery P, Khot A, Anderson MA, Ritchie D, Tam CS, Seymour JF. Lew TE, et al. Among authors: anderson ma. Lancet Haematol. 2023 Feb;10(2):e142-e154. doi: 10.1016/S2352-3026(22)00355-6. Lancet Haematol. 2023. PMID: 36725119 Review.
Fatal Post COVID mRNA-Vaccine Associated Cerebral Ischemia.
McMillan N, Rosenberg HJ, Anderson MP, Pal P, Stephenson K, Fehnel CR. McMillan N, et al. Among authors: anderson mp. Neurohospitalist. 2023 Apr;13(2):156-158. doi: 10.1177/19418744221136898. Epub 2022 Dec 5. Neurohospitalist. 2023. PMID: 37064937 Free PMC article.
Natural and targeted circuit reorganization after spinal cord injury.
Anderson MA, Squair JW, Gautier M, Hutson TH, Kathe C, Barraud Q, Bloch J, Courtine G. Anderson MA, et al. Nat Neurosci. 2022 Dec;25(12):1584-1596. doi: 10.1038/s41593-022-01196-1. Epub 2022 Nov 17. Nat Neurosci. 2022. PMID: 36396975 Review.
Required growth facilitators propel axon regeneration across complete spinal cord injury.
Anderson MA, O'Shea TM, Burda JE, Ao Y, Barlatey SL, Bernstein AM, Kim JH, James ND, Rogers A, Kato B, Wollenberg AL, Kawaguchi R, Coppola G, Wang C, Deming TJ, He Z, Courtine G, Sofroniew MV. Anderson MA, et al. Nature. 2018 Sep;561(7723):396-400. doi: 10.1038/s41586-018-0467-6. Epub 2018 Aug 29. Nature. 2018. PMID: 30158698 Free PMC article.
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
O'Neill WW, Anderson M, Burkhoff D, Grines CL, Kapur NK, Lansky AJ, Mannino S, McCabe JM, Alaswad K, Daggubati R, Wohns D, Meraj PM, Pinto DS, Popma JJ, Moses JW, Schreiber TL, Magnus Ohman E. O'Neill WW, et al. Among authors: anderson m. Am Heart J. 2022 Jun;248:139-149. doi: 10.1016/j.ahj.2022.02.006. Epub 2022 Feb 19. Am Heart J. 2022. PMID: 35192839 Free article. Clinical Trial.
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
VanDyke D, Iglesias M, Tomala J, Young A, Smith J, Perry JA, Gebara E, Cross AR, Cheung LS, Dykema AG, Orcutt-Jahns BT, Henclová T, Golias J, Balolong J, Tomasovic LM, Funda D, Meyer AS, Pardoll DM, Hester J, Issa F, Hunter CA, Anderson MS, Bluestone JA, Raimondi G, Spangler JB. VanDyke D, et al. Among authors: anderson ms. Cell Rep. 2022 Oct 18;41(3):111478. doi: 10.1016/j.celrep.2022.111478. Cell Rep. 2022. PMID: 36261022 Free PMC article.
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
Tam CS, Anderson MA, Pott C, Agarwal R, Handunnetti S, Hicks RJ, Burbury K, Turner G, Di Iulio J, Bressel M, Westerman D, Lade S, Dreyling M, Dawson SJ, Dawson MA, Seymour JF, Roberts AW. Tam CS, et al. Among authors: anderson ma. N Engl J Med. 2018 Mar 29;378(13):1211-1223. doi: 10.1056/NEJMoa1715519. N Engl J Med. 2018. PMID: 29590547 Free article. Clinical Trial.
7,882 results